I would be very interested to hear your analysis of the result. It looked about as expected to me with revenue tracking closely from the first half, but perhaps r&d came in a little higher. I assume your implication of squirrelling away profits would be around r&d spending and d&a accounting practices. Behring is an absolute beast, as expected and vifor is looking like a lousy acquisition, as expected.
Thanks for your analysis this reporting season.
I would be very interested to hear your analysis of the result....
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$285.29 |
Change
1.900(0.67%) |
Mkt cap ! $138.1B | |||
| Open | High | Low | Value | Volume |
| $286.24 | $286.95 | $283.70 | $138.5M | 483.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79 | $285.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $285.40 | 112 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |